Wundrsight raised $400K in Seed Funding Led by Inflection Point Ventures

Wundrsight, a Digital Therapeutics startup, secured $400K in seed funding led by Inflection Point Ventures, with participation from Social Alpha and angel investors. The funds will help expand their hospital and clinic network and advance their VR-based mental health solutions. Established in 2022, Wundrsight pioneers VR and AI therapy in India, targeting mental health conditions like OCD, anxiety, and autism. Backed by Meta, DLabs, IIT Mandi Catalyst, and NASSCOM, the team includes Raunak Swarnkar, CEO with experience at TCS R&D and IBM, and Nishtha Budhiraja, CMO with a decade of clinical expertise.

Vikram Ramasubramanian, Partner, Inflection Point Ventures says, “The mental health crisis is more alarming than ever; solving it with just traditional methods is often limited to accessibility, personalized treatment, and engagement. Many people start therapy but frequently drop off due to ineffective retention and engagement strategies. Wundrsight is at the forefront of addressing these issues by bringing in digital therapeutic and mixed reality technology like Virtual Reality to create personalized, immersive, and effective mental health care experiences. VR augments current solutions, helping to retain and engage users more effectively, ensuring they achieve their results. At IPV, we believe in Wundrsight’s vision to make mental wellness accessible to all through technological innovation.”

“We’re at a pivotal moment in mental health care, especially now as innovative software-based medical devices are getting regulatory approvals for prescriptions,” said Raunak Swarnkar, Co-Founder & CEO of Wundrsight. “Hospitals and clinics globally face immense pressure to provide high-quality, scalable mental health services despite a shortage of clinicians. Our VR-based solutions not only reduce the need for medication but also enhance clinician efficiency, allowing for safe, standardized and effective treatments. This funding will help us expand our reach and impact in India and APAC. We look forward to entering the US market next where VR therapy has received CPT codes for reimbursement from insurance providers.”